TEL: +86 571 56623320    EMAIL: [email protected]

Rabbit Anti-eIF2B epsilon antibody
Rabbit Anti-eIF2B epsilon antibody
CACH; CLE; EI2BE_HUMAN; EIF 2B; eIF 2B GDP GTP exchange factor; eIF 2B GDP GTP exchange factor subunit epsilon; eIF-2B GDP-GTP exchange factor subunit epsilon; EIF2B; EIF2B5; EIF2BE; EIF2Bepsilon; Eukaryotic Translation Initiation Factor 2 Beta Epsilon; E
Total $253.0
(Vip priceV)
Regular members: $202.4
  • NO.:SL14533R
    Clonality:Polyclonal
    Immunogen Species:Rabbit
    React Species:(predicted:Human,Mouse,Rat,Dog,Pig,Cow,Horse,Rabbit,Sheep)
    Applications:WB,IHC-P,IHC-F,ICC/IF,IF,ELISA
    concentration:1mg/ml
  • Goods click count:249
  • Product Spec:
  • Quantity: - +
  • Limit points for buying:0 Points
  • Manual
  • Add to cart Inquiry Add to favorite
All categories
View History [Clear]

Details

Product Name eIF2B epsilon
Chinese Name eIF2B蛋白抗体
Alias CACH; CLE; EI2BE_HUMAN; EIF 2B; eIF 2B GDP GTP exchange factor; eIF 2B GDP GTP exchange factor subunit epsilon; eIF-2B GDP-GTP exchange factor subunit epsilon; EIF2B; EIF2B5; EIF2BE; EIF2Bepsilon; Eukaryotic Translation Initiation Factor 2 Beta Epsilon; Eukaryotic Translation Initiation Factor 2 Beta Epsilon; Eukaryotic translation initiation factor 2B subunit 5 epsilon 82kDa; Eukaryotic translation initiation factor 2B subunit 5 epsilon; LVWM; Translation initiation factor eIF 2B subunit epsilon; Translation initiation factor eIF-2B subunit epsilon.
literatures
Specific References (1) | SL14533R has been referenced in 1 publications.
[IF=15.304] Yao Lei. et al. Phytochemical natural killer cells reprogram tumor microenvironment for potent immunotherapy of solid tumors. BIOMATERIALS. 2022 Jun;:121635 WB ; Mouse.
Research Area transcriptional regulatory factor Epigenetics
Immunogen Species Rabbit
Clonality Polyclonal
React Species (predicted: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, Sheep, )
Applications WB=1:500-2000,IHC-P=1:100-500,IHC-F=1:100-500,ICC/IF=1:100-500,IF=1:100-500,ELISA=1:5000-10000 (Paraffin sections need antigen repair)
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
Theoretical molecular weight 80kDa
Cellular localization The nucleus cytoplasmic
Form Liquid
Concentration 1mg/ml
immunogen KLH conjugated synthetic peptide derived from human eIF2B epsilon: 101-200/721
Lsotype IgG
Purification affinity purified by Protein A
Buffer Solution 1M TBS(pH7.4) with 1% BSA, 3% Proclin300 and 50% Glycerol.
Storage Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
Attention This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
PubMed PubMed
Product Detail This gene encodes one of five subunits of eukaryotic translation initiation factor 2B (EIF2B), a GTP exchange factor for eukaryotic initiation factor 2 and an essential regulator for protein synthesis. Mutations in this gene and the genes encoding other EIF2B subunits have been associated with leukoencephalopathy with vanishing white matter. [provided by RefSeq, Nov 2009]

Function:
Catalyzes the exchange of eukaryotic initiation factor 2-bound GDP for GTP.

Subunit:
Complex of five different subunits; alpha, beta, gamma, delta and epsilon. Interacts with RGS2.

Post-translational modifications:
Phosphorylated at Ser-544 by DYRK2; this is required for subsequent phosphorylation by GSK3B (By similarity). Phosphorylated on serine and threonine residues by GSK3B; phosphorylation inhibits its function.
Polyubiquitinated, probably by NEDD4 (By similarity).

DISEASE:
Defects in EIF2B5 are a cause of leukodystrophy with vanishing white matter (VWM) [MIM:603896]. VWM is a leukodystrophy that occurs mainly in children. Neurological signs include progressive cerebellar ataxia, spasticity, inconstant optic atrophy and relatively preserved mental abilities. The disease is chronic-progressive with, in most individuals, additional episodes of rapid deterioration following febrile infections or minor head trauma. While childhood onset is the most common form of the disorder, some severe forms are apparent at birth. A severe, early-onset form seen among the Cree and Chippewayan populations of Quebec and Manitoba is called Cree leukoencephalopathy. Milder forms may not become evident until adolescence or adulthood. Some females with milder forms of the disease who survive to adolescence exhibit ovarian dysfunction. This variant of the disorder is called ovarioleukodystrophy.

Similarity:
Belongs to the eIF-2B gamma/epsilon subunits family.
Contains 1 W2 domain.

SWISS:
Q13144

Gene ID:
8893

Database links:

Entrez Gene: 8893 Human

Entrez Gene: 224045 Mouse

Entrez Gene: 192234 Rat

Omim: 603945 Human

SwissProt: Q13144 Human

SwissProt: Q8CHW4 Mouse

SwissProt: Q64350 Rat

Unigene: 283551 Human

Unigene: 233855 Mouse

Unigene: 10607 Rat



Partial purchase records(bought amounts latest1)

UsernameQuantitybought time
No***12026-02-22
Total 1 records, divided into1 pages First Prev Next Last

User Comment(Total0User Comment Num)

  • No comment
Total 0 records, divided into1 pages First Prev Next Last
Username: Anonymous user
E-mail:
Rank:
Content:
Verification code: captcha

Call us

+86 571 56623320

Address

Room 1-315, Kongle Changqing Building, No. 160 Guangye Road,Gongshu District, Hangzhou City, Zhejiang Province, China

Join Us with

Leave a message
* To protect against spam, please pass the CAPTCHA test below.
© 2005-2026 SUNLONG BIOTECH CO., LTD Copyright, All Rights Reserved.